<DOC>
	<DOCNO>NCT01059123</DOCNO>
	<brief_summary>The propose study determine whether 6-day duration oral amoxicillin treatment erysipelas non-inferior 14-day standard duration intravenous oral amoxicillin regimen . This trial open evaluation perform blind evaluator .</brief_summary>
	<brief_title>Short Course Amoxicillin Erysipelas</brief_title>
	<detailed_description>To fight increase rate bacterial resistance antibiotic , several study demonstrate efficacy short antibiotic course e.g . acute streptococcal tonsillitis , community acquire pneumonia , urinary tract infection . Erysipelas acute dermo-hypodermal infection due streptococcus . To date resistance thesis bacteria amoxicillin described . The diagnosis erysipelas clinical . Thus , short course antibiotic good regimen test erysipelas treatment . To date control trial concern efficacy oral amoxicillin erysipelas treatment . Expected advantage demonstration non inferiority short oral amoxicillin treatment erysipelas : reduction antibiotic selective pressure , cost , adverse event cause infusion hospitalisation .</detailed_description>
	<mesh_term>Erysipelas</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Males female ≥ 18 year age First episode erysipelas low leg define acute well delineate inflammation last less 5 day T°≥ 38°5 least past 5 day chill . Score ≥3 : oedema , erythema , pain score 0 3 : 0= none , 1= moderate , 3= severe Written inform consent provide patient available health insurance accept condition trial Erysipelas 5 day Score &lt; 3 Septic shock Clinical sign necrotizing cellulitis fasciitis , bullous lesion related necrosis , purpuric lesion superficial cutaneous necrosis . Past history erysipelas low leg Erysipelas low leg Bilateral erysipelas Bite occur precede 7 day . Diabetic foot patient previously receive systemic antibiotherapy within last 5 day ( except one two dos within last 24 hour ) History hypersensitivity allergic reaction betalactam drug Known renal Hepatic failure Known HIV infection Female patient pregnant , lactate ( breast milk feeding ) , child bear potential use acceptable method birth control Impossibility stop immunosuppressive treatment , systemic corticosteroid nonsteroidal antiinflammatory drug . Severe gastrointestinal disease , dysphagia pathology prevent oral administration treatment . Denied sign write informed consent Unable unwilling adhere studyspecified procedure restriction Evolutive cancer treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Amoxicillin</keyword>
	<keyword>Erysipelas</keyword>
	<keyword>Short course</keyword>
</DOC>